Multicenter Non-interventional Study to Investigate Drug Utilization of Pomalidomide in Clinical Practice for the Treatment of Relapsed/Refractory Multiple Myeloma (rrMM)
Phase of Trial: Phase IV
Latest Information Update: 06 Mar 2018
At a glance
- Drugs Dexamethasone (Primary) ; Pomalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- Sponsors Celgene Corporation
- 01 Sep 2016 Planned End Date changed from 1 Sep 2016 to 1 Sep 2019.
- 01 Sep 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2019.
- 25 Sep 2015 New trial record